The earnings call highlights several strategic initiatives and resolutions, such as pediatric revenue growth and successful transition plans, which are promising for future growth. However, the current financial performance is challenged by a significant revenue decline, reduced gross margins, and increased operating losses. While there are positive steps being taken, the immediate financial indicators present a negative outlook.

Company Guidance -

Q3 2025

During the Nuwellis Second Quarter 2025 Earnings Conference Call, management provided key guidance and insights into their strategic focus and financial performance. The company reported a revenue of $1.7 million for the second quarter, representing a 21% year-over-year decline, primarily due to a temporary back order issue with a sterilization vendor affecting approximately $400,000 in revenue. Despite this, pediatric revenues grew by 23%, while heart failure and critical care revenues saw declines of 53% and 35%, respectively. The gross margin dropped to 55.5% from 67.2% the previous year, attributed to lower production volumes. Operating expenses increased slightly by 2% to $3.9 million, resulting in an operating loss of $2.9 million. The company ended the quarter with $4.5 million in cash and remains debt-free, supported by a recent $5 million capital raise. Going forward, Nuwellis plans to focus on key growth areas in cardiac surgery, pediatrics, and outpatient heart failure, with expectations of operational efficiencies and cost savings from transitioning manufacturing to KDI Precision Manufacturing.

Pediatric Revenue Growth

Pediatric revenues increased by 23% compared to the second quarter of 2024, reflecting strong demand from established hospital customers and new centers.

Resolution of Sterilization Vendor Issue

The temporary back order issue due to a sterilization vendor was resolved in the first week of July, allowing the company to build inventory and support future sales.

Transition to KDI Precision Manufacturing

Transition to KDI Precision Manufacturing is expected to result in operational efficiencies and cost savings over the next 12 months.

Increased Reimbursement for Heart Failure

Reimbursement increased from $413 to $1,639 per day for outpatient clinics, which is expected to drive growth in the heart failure segment.

Successful Capital Raise

The company completed a $5 million gross capital raise, bolstering its financial position and supporting core growth initiatives.

Nuwellis (NUWE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

NUWE Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	- / -	73.08	―	―	―
Aug 14, 2025	2025 (Q2)	-18.90 / -60.99	-791.7	92.30% (+730.71)	―
May 13, 2025	2025 (Q1)	-18.90 / -28.98	-882	96.71% (+853.02)	―
Mar 11, 2025	2024 (Q4)	-18.06 / -18.48	-3292.8	99.44% (+3274.32)	―
Nov 11, 2024	2024 (Q3)	-53.76 / 73.08	-2660.7	102.75% (+2733.78)	―
Aug 13, 2024	2024 (Q2)	-346.29 / -791.70	-5365.5	85.24% (+4573.80)	―
May 07, 2024	2024 (Q1)	-1558.20 / -882.00	-8467.2	89.58% (+7585.20)	―
Mar 05, 2024	2023 (Q4)	-2043.30 / -3292.80	-7350	55.20% (+4057.20)	―
Nov 07, 2023	2023 (Q3)	-4577.97 / -2660.70	-54390	95.11% (+51729.30)	―
Aug 08, 2023	2023 (Q2)	-5914.30 / -5365.50	-60270	91.10% (+54904.50)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

NUWE Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 14, 2025	$5.50	$5.64	+2.55%
May 13, 2025	$41.58	$41.96	+0.91%
Mar 11, 2025	$52.92	$50.82	-3.97%
Nov 11, 2024	$76.02	$86.10	+13.26%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Nuwellis (NUWE) report earnings?

Nuwellis (NUWE) is schdueled to report earning on Nov 11, 2025, TBA (Confirmed).

What is Nuwellis (NUWE) earnings time?

Nuwellis (NUWE) earnings time is at Nov 11, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is NUWE EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing